维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="CuPPone F"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Weekly epirubicin and paclitaxel with anulyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II study 显示文摘	Nistic C Bria E Cuppone F	2007	Antieaneer Drugs2007，18，6：	1
2	Trastuzumab cardio toxicity:biological hypotheses and clinical open issues显示文摘	Bria E Cuppone F Milella M	2015	Expert Opin Biol Ther2015，8，12：	1
3	Benefit of taxanes as adju- vant chemotherapy for early breast cancer: pooled analysis of 15 500 patients 显示文摘	Bria E Nistico C Cuppone F	2006	Cancer2006，106，11：	1
4	Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer:meta-analysis of randomized trials显示文摘	Cuppone F Bria E Giannarelli D	2010	BMC Cancer2010，10，9：	1
5	Benefit of taxanes as Adjuvant chemotherapy for early breast cancer:pooled analysis of15500 patients显示文摘	Bria E Nistico C Cuppone F	2006	Cancer2006，106，11：	1
6	Adjuvant chemotherapy for non-small cell lung cancer显示文摘	Bria E CuPPone F Cecere FL	2007	J Thorae Oneol2007，，：	1
7	Benefit of taxanes as adjuvant chemotherapy, for early breast cancer: pooled analysis of 15 500 patients显示文摘	Bria E Nistico C Cuppone F	2006	Cancer2006，106，11：	1
8	Impact of hormonaltreatment duration in combination with radiotherapy for local-ly advanced prostate cancer: meta-analysis of randomized trial显示文摘	Cuppone F Bria E Giannarelli D	2010	BMZ Cancer2010，10，：	1
9	Benefit of taxanes as adjuvant chemotherapy for early breast cancer:pooled analysis of 15,500 patients显示文摘	Bria E Nistico C Cuppone F	2006	Cancer2006，106，11：	1
10	Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials显示文摘	Cuppone F Bria E Vaccaro V	2011	J Exp Clin Cancer Res2011，30，1：	1
11	Weekly docetaxel as second line chemotherapy for advanced non-sinall cell lung cancer: recta-analysis of randomized trials显示文摘	Bria E Cuppone F Ciccarese M	2006	Cancer Treat Rev2006，32，8：	1
12	Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials 显示文摘	Bria E Cuppone F Fornier M	2008	Breast Cancer Res Treat2008，109，2：	1
13	Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials显示文摘	Bria E Cuppone F Ciccarese M	2006	Cancer Treat Rev2006，32，8：	1
14	Peripheral neurotoxicity of weekly paclitaxel chemotherapy: a schedule or a dose is- sue?显示文摘	Pace A Nistico C Cuppone F	2007	Clinic Breast Cancer2007，7，7：	1
15	Weekly docetaxel as second line chemotherapy for advanced non-small cell lung cancer:Meta-analysis of randomized trials显示文摘	Bria E Cuppone F Ciccarese M	2006	Cancer Treat Rev2006，32，8：	1
16	Weekly docetaxel as second line chemotherapy for advanced non - small - cell lung cancer: Meta - analysis of randomized trials 显示文摘	Bria E Cuppone F Ciccarese M	2006	Cancer Treat Rev2006，32，8：	1
17	Adjuvant chemothera- py for non-small cell lung cancer 显示文摘	Bria E Cuppone F Cecere FL	2007	J Thorac Oncol2007，2，5：	1
18	Trastuzumab cardiotoxicity:biological hypotheses and clinical open issues显示文摘	Bria E Cuppone F Milella M	2008	Expert Opin Biol Ther2008，8，12：	1
19	Early recurrence risk:aromatase inhibitors versus tamoxifen显示文摘	Bria E Carlini P Cuppone F	2010	Expert Rev Anticancer Ther2010，10，8：	1
20	Capecitabine (CAP) versus 5-fluorouracil (FU) in combination with oxaliplatin(OX) as lst-line chemotherapy(CT) for advanced colorectal cancer(ARAC):meta-analysis of randomized clinical trials (RCT)显示文摘	Cuppone F Bria E Sperduti I	2008	J Clin Oncol2008，26，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示